Research Topics
| Bruce E HillnerSummaryAffiliation: Virginia Commonwealth University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registryBruce E Hillner
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA
Med Care 51:361-7. 2013....
Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?Bruce E Hillner
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, USA
J Am Coll Radiol 9:33-41. 2012..Whether physicians use PET as a replacement for or in addition to CT, MRI, or bone scintigraphy (BS) is uncertain...
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohortsBruce E Hillner
Department of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298 0170, USA
J Nucl Med 53:831-7. 2012....
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET RegistryBruce E Hillner
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, 1101 E Marshall St, Room 7013, Richmond, VA 23298 0170, USA
J Clin Oncol 26:2155-61. 2008..The National Oncologic PET Registry (NOPR) was developed to meet these coverage requirements and to assess how PET affects care decisions...
Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registryBruce E Hillner
Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA
J Nucl Med 49:1928-35. 2008..Here, we present results for specific cancer types and indications for testing...
Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET RegistryBruce E Hillner
Department of Internal Medicine, Virginia Commonwealth University, 1101 E Marshall St Room 7013, Richmond, VA 23298 0170, USA
Mol Imaging Biol 13:161-5. 2011..This study seeks to assess the impact of dedicated brain positron emission tomography (PET) with 2-deoxy-2-[(18)F]fluoro-D-glucose on intended management of patients with primary and metastatic brain tumors...
The National Oncologic PET Registry (NOPR): design and analysis planBruce E Hillner
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
J Nucl Med 48:1901-8. 2007..CONCLUSION: The NOPR will allow an accurate assessment of the impact of PET on intended patient management across a wide spectrum of cancer indications...
Allocating cancer-directed expenditures: tensions between prevention, early detection and treatment is unnecessaryBruce E Hillner
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
Recent Results Cancer Res 188:1-9. 2011..Changing behaviors, incentives, expectations, and the framing of treatment effects are necessary to "bend" the current unrelenting cancer care cost curve...
The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET RegistryBruce E Hillner
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298 0170, USA
Cancer 115:410-8. 2009..Under the Medicare 'coverage with evidence development' policy, PET (and integrated PET/computed tomography) became a covered service for treatment monitoring if prospective registry data were collected...
Concrete options and ideas for increasing value in oncology care: the view from one trenchThomas J Smith
Massey Cancer Center, Virginia Commonwealth University Health System, Richmond, Virginia, USA
Oncologist 15:65-72. 2010..These actions will likely control costs, but in the short term will cause significant distress among patients, families, and health care practitioners...
Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancerBruce E Hillner
Department of Internal Medicine, Virginia Commonwealth University, Richmond 23298, USA
Cancer 101:1311-22. 2004....
A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoidsLenore M Buckley
Virginia Commonwealth University, Richmond 23298, USA
J Rheumatol 30:132-8. 2003....
Diagnosis of lower-extremity deep vein thrombosis in outpatients with musculoskeletal disorders: a national survey study of physical therapistsDaniel L Riddle
Department of Physical Therapy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298 0224, USA
Phys Ther 84:717-28. 2004....
Trends in clinical trials reports in common cancers between 1989 and 2000Bruce E Hillner
Department of Internal Medicine, the Outcomes Research Institute, and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298 0170, USA
J Clin Oncol 21:1850-8. 2003..This exploratory study sought to describe the epidemiologic patterns of clinical trial reports in common cancers...
Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinomaBruce E Hillner
Department of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, USA
Cancer 104:1871-84. 2005..The trade-offs between costs and survival for these two regimens have not been explored...
Explaining marginal benefits to patients, when "marginal" means additional but not necessarily smallThomas J Smith
Division of Hematology Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA
Clin Cancer Res 16:5981-6. 2010..These difficult conversations can be done if the oncologist has the right medical information, the right script, and some decision aids...
Clinical decisions associated with positron emission tomography in a prospective cohort of patients with suspected or known cancer at one United States centerBruce E Hillner
Division of General Medicine, Virginia Commonwealth University, 1101 E Marshall St, Sanger Hall, Room 7 083, Richmond, VA 23298, USA
J Clin Oncol 22:4147-56. 2004..PET has been observed to be more accurate than other imaging in cancer patients, but the impact of PET on management in routine practice is uncertain...
A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitisJill K J Gaidos
Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA, USA
Liver Int 28:650-8. 2008..Liver biopsy (LB) is the only way to determine the severity of disease. However, LB is invasive, has complications and financial costs. The aim of this study is to determine the benefits of early LB for diagnosis and early treatment...
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancerDonald A Podoloff
J Natl Compr Canc Netw 5:S1-S22; quiz S23-2. 2007..This report summarizes the proceedings of this meeting, including discussions of the background of PET, possible future developments, and the role of PET in oncology...
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancerBruce E Hillner
J Clin Oncol 21:4042-57. 2003..Although new data addressing when to stop therapy, alternative doses or schedules for administration, and how to best coordinate bisphosphonates with other palliative therapies are needed, they are not currently being investigated...
Barriers to clinical trial enrollment: are state mandates the solution?Bruce E Hillner
J Natl Cancer Inst 96:1048-9. 2004
Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breastW Warren Suh
Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA
Int J Radiat Oncol Biol Phys 61:1054-61. 2005..To assess the cost-effectiveness of radiation therapy (RT) in patients with ductal carcinoma in situ (DCIS) after breast-conserving surgery (BCS)...
Caring for older women with breast cancer: can observational research fill the clinical trial gap?Bruce E Hillner
J Natl Cancer Inst 98:660-1. 2006
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?Bruce E Hillner
J Clin Oncol 25:611-3. 2007
The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence developmentMatthew J Lindsay
Foley Hoag, LLP, 155 Seaport Blvd, Boston, MA 02210 2600, USA
AJR Am J Roentgenol 188:1109-13. 2007..By linking access to PET for virtually all Medicare beneficiaries to the collection of clinically valuable evidence, the NOPR represents the cutting edge of the CED approach...
Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancerRichard R Love
University of Wisconsin Comprehensive Cancer Center, 610 Walnut Street, Madison, WI 53705 2397, USA
J Clin Oncol 20:2559-66. 2002..Approximately 350,000 new cases of breast cancer are diagnosed annually in premenopausal Asian women who have lower levels of estrogen than western women...
Genomics-based prognosis and therapeutic prediction in breast cancerStefanie S Jeffrey
Department of Surgery, Stanford University School of Medicine, Stanford, California, 94305 5494, USA
J Natl Compr Canc Netw 3:291-300. 2005..We believe that the characterization and discernment of different systems among breast cancers is crucial for understanding drug sensitivity and resistance mechanisms and for guiding therapy...
Do cancer centers designated by the National Cancer Institute have better surgical outcomes?Nancy J O Birkmeyer
Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, USA
Cancer 103:435-41. 2005..In the current study, the authors assessed whether patients at NCI cancer centers compared with patients at control hospitals had lower mortality rates after major cancer surgery...
Taking action on the volume-quality relationship: how long can we hide our heads in the colostomy bag?Thomas J Smith
J Natl Cancer Inst 95:695-7. 2003
